Rhythm Pharmaceuticals Announces New Employment Inducement Grants
September 16, 2024 16:01 ET
|
Rhythm Pharmaceuticals, Inc.
BOSTON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare...
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
September 15, 2024 08:45 ET
|
Lantheus Holdings, Inc.
Study met its primary endpoint, demonstrating significant improvement in radiographic progression-free survival Overall Response Rate was 38.1% vs. 12.0% for the ARPI switch arm, including 9.3%...
Apollo Commercial Real Estate Finance, Inc. Declares Quarterly Common Stock Dividend
September 11, 2024 16:30 ET
|
Apollo Commercial Real Estate Finance, Inc.
NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Apollo Commercial Real Estate Finance, Inc. (the “Company”) (NYSE:ARI) today announced the Board of Directors declared a dividend of $0.25 per share of...
Koryx Copper Announces Updated Mineral Resource for the Company’s Flagship Haib Copper Development Project in Namibia
September 10, 2024 09:06 ET
|
Koryx Copper Inc.
VANCOUVER, British Columbia, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Koryx Copper Inc. (“Koryx” or the "Company") (TSX-V: KRY) today announced an updated resource statement for the Haib Copper Project...
HEKA, the Inventor of AI Mattress, Launches the Sixth-Generation AI Mattress, Ushering in a New Era of Healthy Sleep
September 08, 2024 21:13 ET
|
iFutureLab Inc.
Recently, in Silicon Valley, the forefront of technological innovation, HEKA once again led the trend by globally launching its new generation AI mattress
RYBREVANT®▼ (amivantamab) plus lazertinib show strong favourable overall survival trend versus osimertinib in EGFR-mutated advanced lung cancer
September 08, 2024 14:30 ET
|
Janssen Cilag International NV
New longer-term data from the MARIPOSA study confirm superior outcomes of amivantamab plus lazertinib regimen compared to osimertinib monotherapy as first-line therapy1 ...
Multiple Regression, Logistic Regression, and Cox Regression Core Principles and Applications: ON-DEMAND COURSE
September 02, 2024 05:54 ET
|
Research and Markets
Dublin, Sept. 02, 2024 (GLOBE NEWSWIRE) -- The "Multiple Linear Regression, Logistic Regression, and Survival Analysis" webinar has been added to ResearchAndMarkets.com's offering. In this...
Clark, SmithGroup and HKS Celebrate Groundbreaking of the New El Paso VA Health Care Center
August 29, 2024 12:10 ET
|
Clark Construction Group
EL PASO, TEXAS, Aug. 29, 2024 (GLOBE NEWSWIRE) -- On August 28, 2024 the design-build team of Clark Construction Group and the SmithGroup + HKS Joint Venture celebrated the groundbreaking of the new...
QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases
August 28, 2024 16:05 ET
|
QIAGEN N.V.
Venlo, the Netherlands, Aug. 28, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its Master Collaboration Agreement with AstraZeneca to...
What’s New in Mammoth Lakes and at Mammoth Mountain for Winter 2024/2025
August 28, 2024 13:00 ET
|
Mammoth Mountain Ski Area, LLC
Mammoth Lakes, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Mammoth Lakes is gearing up for another unreal winter season. The leaves will change soon to show off a spectacular array of colors before...